Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

SG Cowen Cuts Vital Signs to 'Market Perform'


SG Cowen lowered its rating on Vital Signs (VITL) to market perform.

Analyst Matthew Dodds says he downgraded the medical products maker to market perform, from outperform, as the 43 cents second-quarter earnings per share from continuing operations (excluding charges) was 9 cents below his and the consensus estimates.

Dodds notes the company continues to suffer from gross margin declines, and rising selling, general, and administrative costs. He says Vital Signs offered limited earnings per share guidance, projecting a quarter-over-quarter operating earnings per share improvement in the third quarter, similar to the 51 cents in the first quarter. Dodds notes an inflammatory civil lawsuit against Vital Signs by a former CEO.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus